NEW YORK, NY / ACCESSWIRE / June 9, 2023 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
LivePerson, Inc. (NASDAQ:LPSN)
CONTACT JAKUBOWITZ ABOUT LPSN:
https://claimyourloss.com/securities/liveperson-class-action-loss-submission-form/?id=40612&from=1
Class Period : May 10, 2022 - March 16, 2023
Lead Plaintiff Deadline : June 23, 2023
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) LivePerson failed to address any material weaknesses with internal controls; (2) LivePerson's third quarter financial statements, ended in September 30, 2022 failed to disclose its subsidiary, WildHealth's, suspension of Medicare reimbursement; (3) as a result, LivePerson's fourth quarter 2022 revenue would be affected; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Icahn Enterprises L.P. (NASDAQ:IEP)
CONTACT JAKUBOWITZ ABOUT IEP:
https://claimyourloss.com/securities/icahn-enterprises-class-action-loss-submission-form/?id=40612&from=1
Class Period : August 2, 2018 - May 9, 2023
Lead Plaintiff Deadline : July 10, 2023
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Icahn Enterprises was inflating its net asset value; (ii) the Company was using money taken in from new investors to pay out dividends to old investors; (iii) as a result, the Company would become the subject of criminal and/or regulatory scrutiny; and (iv) as a result of the foregoing, Defendant's positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Charles River Laboratories International, Inc. (NYSE:CRL)
CONTACT JAKUBOWITZ ABOUT CRL:
https://claimyourloss.com/securities/charles-river-class-action-loss-submission-form/?id=40612&from=1
Class Period : May 5, 2020 - February 21, 2023
Lead Plaintiff Deadline : July 18, 2023
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Charles River had engaged in illegal activity with respect to its importation of non-human primates for research; (2) as a result, Charles River was at a heightened risk of criminal and regulatory investigation by, inter alia, the U.S. Department of Justice; (3) as a result, Charles River would be forced to suspend shipments of primates from Cambodia; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (628) 895-0423
F: (212) 537-5887
SOURCE: Jakubowitz Law
View source version on accesswire.com:
https://www.accesswire.com/760273/LAWSUITS-FILED-AGAINST-LPSN-IEP-and-CRL--Jakubowitz-Law-Pursues-Shareholders-Claims
